64 related articles for article (PubMed ID: 22098992)
21. Hypoxia enhances transcriptional activity of androgen receptor through hypoxia-inducible factor-1α in a low androgen environment.
Mitani T; Yamaji R; Higashimura Y; Harada N; Nakano Y; Inui H
J Steroid Biochem Mol Biol; 2011 Jan; 123(1-2):58-64. PubMed ID: 21056661
[TBL] [Abstract][Full Text] [Related]
22. Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF-7 breast cancer cells.
Kumar P; Mark PJ; Ward BK; Minchin RF; Ratajczak T
Biochem Biophys Res Commun; 2001 Jun; 284(1):219-25. PubMed ID: 11374893
[TBL] [Abstract][Full Text] [Related]
23. Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response.
Sun NK; Huang SL; Chang PY; Lu HP; Chao CC
Oncotarget; 2014 Dec; 5(23):11939-56. PubMed ID: 25460502
[TBL] [Abstract][Full Text] [Related]
24. FK506-binding protein 52 phosphorylation: a potential mechanism for regulating steroid hormone receptor activity.
Cox MB; Riggs DL; Hessling M; Schumacher F; Buchner J; Smith DF
Mol Endocrinol; 2007 Dec; 21(12):2956-67. PubMed ID: 17717070
[TBL] [Abstract][Full Text] [Related]
25. The environmental endocrine disruptor p-nitrophenol interacts with FKBP51, a positive regulator of androgen receptor and inhibits androgen receptor signaling in human cells.
Wu D; Tao X; Chen ZP; Han JT; Jia WJ; Zhu N; Li X; Wang Z; He YX
J Hazard Mater; 2016 Apr; 307():193-201. PubMed ID: 26780698
[TBL] [Abstract][Full Text] [Related]
26. The immunophilin FKBP52 specifically binds to tubulin and prevents microtubule formation.
Chambraud B; Belabes H; Fontaine-Lenoir V; Fellous A; Baulieu EE
FASEB J; 2007 Sep; 21(11):2787-97. PubMed ID: 17435176
[TBL] [Abstract][Full Text] [Related]
27. D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability.
Knudsen KE; Cavenee WK; Arden KC
Cancer Res; 1999 May; 59(10):2297-301. PubMed ID: 10344732
[TBL] [Abstract][Full Text] [Related]
28. The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.
Leach DA; Trotta AP; Need EF; Risbridger GP; Taylor RA; Buchanan G
Prostate; 2017 Feb; 77(2):185-195. PubMed ID: 27718274
[TBL] [Abstract][Full Text] [Related]
29. A naturally occurring mutation in the human androgen receptor of a subject with complete androgen insensitivity confers binding and transactivation by estradiol.
Bonagura TW; Deng M; Brown TR
Mol Cell Endocrinol; 2007 Jan; 263(1-2):79-89. PubMed ID: 17011702
[TBL] [Abstract][Full Text] [Related]
30. DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation.
Haelens A; Verrijdt G; Callewaert L; Christiaens V; Schauwaers K; Peeters B; Rombauts W; Claessens F
Biochem J; 2003 Jan; 369(Pt 1):141-51. PubMed ID: 12350223
[TBL] [Abstract][Full Text] [Related]
31. Re: lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs.
Atala A
J Urol; 2014 May; 191(5):1470-1. PubMed ID: 24745541
[No Abstract] [Full Text] [Related]
32. RWDD1 interacts with the ligand binding domain of the androgen receptor and acts as a coactivator of androgen-dependent transactivation.
Grötsch H; Kunert M; Mooslehner KA; Gao Z; Struve D; Hughes IA; Hiort O; Werner R
Mol Cell Endocrinol; 2012 Jul; 358(1):53-62. PubMed ID: 22406838
[TBL] [Abstract][Full Text] [Related]
33. Androgen Signaling in Esophageal Adenocarcinoma Cell Lines In Vitro.
Palethorpe HM; Drew PA; Smith E
Dig Dis Sci; 2017 Dec; 62(12):3402-3414. PubMed ID: 29052817
[TBL] [Abstract][Full Text] [Related]
34. RanBP10 acts as a novel coactivator for the androgen receptor.
Harada N; Yokoyama T; Yamaji R; Nakano Y; Inui H
Biochem Biophys Res Commun; 2008 Mar; 368(1):121-5. PubMed ID: 18222118
[TBL] [Abstract][Full Text] [Related]
35. Ala 586 Asp mutation in androgen receptor disrupts transactivation function without affecting androgen binding.
Rajender S; Gupta NJ; Chakrabarty B; Singh L; Thangaraj K
Fertil Steril; 2009 Mar; 91(3):933.e23-8. PubMed ID: 19062009
[TBL] [Abstract][Full Text] [Related]
36. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).
Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL
Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543
[TBL] [Abstract][Full Text] [Related]
37. Effects of mitogens on androgen receptor-mediated transactivation.
Reinikainen P; Palvimo JJ; Jänne OA
Endocrinology; 1996 Oct; 137(10):4351-7. PubMed ID: 8828495
[TBL] [Abstract][Full Text] [Related]
38. Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system.
Wafa LA; Cheng H; Rao MA; Nelson CC; Cox M; Hirst M; Sadowski I; Rennie PS
Biochem J; 2003 Oct; 375(Pt 2):373-83. PubMed ID: 12864730
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte nuclear factor-3 alpha (HNF-3alpha) negatively regulates androgen receptor transactivation in prostate cancer cells.
Lee HJ; Hwang M; Chattopadhyay S; Choi HS; Lee K
Biochem Biophys Res Commun; 2008 Mar; 367(2):481-6. PubMed ID: 18178153
[TBL] [Abstract][Full Text] [Related]
40. Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity.
Ting HJ; Bao BY; Hsu CL; Lee YF
Endocrine; 2005 Feb; 26(1):1-9. PubMed ID: 15805579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
